Scholars Central

Conference abstract

Novel approaches to reducing inflammation following respiratory virus infections - A focus on respiratory syncytial virus

Authors: Suresh Mahalingam

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

I ndiscriminate targeting of cytokines in inflammatory disease has been met with major limitations. We have discovered a means to manipulate key cytokine and chemokine responses to selectively target these responses against inflammation. We demonstrate that small receptor antagonist that target TNF signaling or small molecule inhibitor that target the chemokines MCPs are effective in ameliorating RSV disease in mice. Histological analysis of lung tissues showed a reduction in inflammatory infiltrate in infected mice treated with these inhibitors. Importantly, treatment of mice with these inhibitors does not compromise antiviral immunity. These results suggest that these small molecule inhibitors may be useful in treating RSV-induced inflammation in humans. These findings represent novel approaches to targeting inflammatory processes caused by RSV infection. The findings will be discussed

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of AIDS & Clinical Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of AIDS & Clinical Research
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Suresh Mahalingam”